Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer

被引:0
|
作者
Daniel E. Lage
M. Dror Michaelson
Richard J. Lee
Joseph A. Greer
Jennifer S. Temel
Christopher J. Sweeney
机构
[1] Massachusetts General Hospital Cancer Center,
[2] Dana-Farber Cancer Institute,undefined
[3] Harvard Medical School,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1181 / 1188
页数:7
相关论文
共 50 条
  • [1] Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer
    Lage, Daniel E.
    Michaelson, Dror M.
    Lee, Richard J.
    Greer, Joseph A.
    Temel, Jennifer S.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
  • [2] Outcomes of older men receiving docetaxel for metastatic hormone-sensitive prostate cancer
    Lage, Daniel E.
    Michaelson, M. Dror
    Lee, Richard J.
    Greer, Joseph A.
    Temel, Jennifer S.
    Sweeney, Christopher J.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2021, 24 (04) : 1181 - 1188
  • [3] Docetaxel for hormone-sensitive metastatic prostate cancer
    Baker, Holly
    LANCET ONCOLOGY, 2015, 16 (09): : E432 - E432
  • [4] Audit of febrile neutropenic (FN) episodes in men receiving docetaxel for hormone-sensitive metastatic prostate cancer (HSMPC)
    Raby, S.
    Mahil, J.
    Hughes, C.
    Lyons, J.
    Patel, K.
    Elliott, T.
    Conroy
    CLINICAL ONCOLOGY, 2016, 28 : S8 - S8
  • [6] Management of Metastatic Hormone-Sensitive Prostate Cancer: Is Docetaxel Needed?
    Kartolo, Adi
    Tannock, Ian F.
    Badillo, Francisco E. Vera
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (31) : 3573 - +
  • [7] Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice
    Lendorf, Maria Elisabeth
    Petersen, Peter Meidahl
    Svendsen, Andrea Steen
    Lindberg, Henriette
    Brasso, Klaus
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 24 : 25 - 33
  • [8] Docetaxel Treatment for Metastatic Hormone-sensitive Prostate Cancer in Daily Practice
    de Groot, Ietsen
    Brinkman, Ithamar
    Luijendijk-de Bruin, Daphne
    Poort, Sharon
    van Rooijen, Johan M.
    EUROPEAN UROLOGY OPEN SCIENCE, 2021, 33 : 48 - 55
  • [9] Febrile Neutropenia Rates in Men Treated with Docetaxel Chemotherapy for Metastatic Hormone-sensitive Prostate Cancer Reply
    Vicini, F.
    Shah, C.
    Mantz, C.
    CLINICAL ONCOLOGY, 2016, 28 (09) : 612 - 613
  • [10] Metastatic hormone-sensitive prostate cancer
    Gravis, Gwenaelle
    Salem, Naji
    Walz, Jochen
    BULLETIN DU CANCER, 2015, 102 (01) : 57 - 64